Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Werner-Wasik

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Radiation Oncology (London, England)|December 29, 2012
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort studyXinglei Shen, David W Andrews, Robert C Sergott, et al.
Journal of Neuro-Oncology|March 25, 2020
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastomaAndrew Song, Voichita Bar-Ad, Nina Martinez, et al.
Journal of Neuro-Oncology|January 30, 2016
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomasWenyin Shi, Joshua D Palmer, Maria Werner-Wasik, et al.
Journal of Neuro-Oncology|January 9, 2021
Resected WHO grade I meningioma and predictors of local controlKamila Nowak-Choi, Joshua D Palmer, James Casey, et al.
Radiation Oncology (London, England)|May 29, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinomaSpencer J Poiset, Sophia Shah, Louis Cappelli, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomasRobert B Den, Mitchell Kamrava, Zhi Sheng, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Radiation Oncology (London, England)|December 29, 2012
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort studyXinglei Shen, David W Andrews, Robert C Sergott, et al.
Journal of Neuro-Oncology|March 25, 2020
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastomaAndrew Song, Voichita Bar-Ad, Nina Martinez, et al.
Journal of Neuro-Oncology|January 30, 2016
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomasWenyin Shi, Joshua D Palmer, Maria Werner-Wasik, et al.
Journal of Neuro-Oncology|January 9, 2021
Resected WHO grade I meningioma and predictors of local controlKamila Nowak-Choi, Joshua D Palmer, James Casey, et al.
Radiation Oncology (London, England)|May 29, 2024
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinomaSpencer J Poiset, Sophia Shah, Louis Cappelli, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomasRobert B Den, Mitchell Kamrava, Zhi Sheng, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
Pageof 16